It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: HawkEyi
a reply to: Grenade
Some people wont listen. Because they would trust whatever the MSM/Box says.
Source: www.foxnews.com...
"And what we mean by that: if a child goes into the hospital, they automatically get tested for COVID and they get counted as a COVID-hospitalized individual, when, in fact, they may go in for a broken leg or appendicitis or something like that.
So it’s over counting the number of children who are, quote, hospitalized with COVID as opposed to because of COVID," Fauci said.
originally posted by: NightSkyeB4Dawn
a reply to: carewemust
I had a case at a local hospital recently. No bed shortages. But my patient was a 20 year old, that had been admitted for newly diagnosed heart issues, after vaccination.
One of the nurses said it is scary, the number of young people that have been admitted for cardiac issues.
She also said there was an uptick on still births and spontaneous abortions.
I did not discuss any of this with her. I was on her court. I didn't ask questions. I just listened. I could tell she was frustrated and none of it seemed right to her. She just needed someone outside of the hospital politics to vent to.
Source: www.reuters.com...
Jan 31 (Reuters) - Pfizer Inc (PFE.N) and Germany's BioNTech SE (22UAy.DE) are expected to submit an emergency use authorization request as early as Tuesday to the U.S. Food and Drug Administration (FDA) for vaccines for children aged six months to 5 years, the Washington Post reported on Monday.
Coronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorization of a two-shot regimen in the coming weeks, the Post reported, citing people briefed on the situation.
originally posted by: carewemust
Jan 31 (Reuters) - Pfizer Inc (PFE.N) and Germany's BioNTech SE (22UAy.DE) are expected to submit an emergency use authorization request as early as Tuesday to the U.S. Food and Drug Administration (FDA) for vaccines for children aged six months to 5 years, the Washington Post reported on Monday.